Hair Loss Clinical Trial
Official title:
Cleansing Device for the Treatment of Scalp and Hair Conditions
NCT number | NCT05319444 |
Other study ID # | RFarah |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 30, 2022 |
Est. completion date | July 2024 |
The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | July 2024 |
Est. primary completion date | July 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Participants must qualify for one of the following scalp conditions based on clinical opinion of a board-certified dermatologist: healthy scalp, dandruff, seborrheic dermatitis, or hair loss disease - All Women of Child Bearing Potential must indicate use of two of the following contraceptive methods. The WaterPik device uses an ultrasonic technology which includes ultrasound. Unnecessary ultrasound is not recommended for pregnant women. - Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, or transdermal) - Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable) - Intrauterine device (IUD) - Intraurerine hormone-releasing system (IUS) - Vasectomized partner - Sexual abstinence - Barrier method, such as a condom Exclusion Criteria: - Non-English speaking - Exclusion related to pregnancy, lactation, or plans to become pregnant over the course of the study (based on self-report from the participant) - Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements |
Country | Name | City | State |
---|---|---|---|
United States | University of Minnesota | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
University of Minnesota |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Adherent Scalp Flaking Scale (ASFS) | The presence of dandruff flakes adhereing to the scalp in 8 defined areas is rated on a scale of 0-10 per area, where 0 indicates no flakes and 10 indicates heavy flaking. This is combined for total scores ranging from 0-80. | 4 weeks | |
Secondary | Change in Erythema Score | The presence of erythema is rated on a scale of 0-4, where 0 indicates None, 1 indicates Minimal - barely perceptible erythema, 2 indicates Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema, 3 indicates Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red), and 4 indicates Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema. The higher score means a worse outcome. | 4 weeks | |
Secondary | Change in Patient Sensory Assessment of Scalp & Hair Score | This Score is based on 12 descriptions that patients rate 0-10 to assess the condition of their scalp and hair. A higher score means a worse outcome. | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT05019066 -
Oral Herbal Combination Formulation and Hair Growth in Women
|
N/A | |
Recruiting |
NCT05502796 -
Natural History and Pathogenesis of Alopecia in Children and Adults
|
||
Completed |
NCT00981461 -
Treatment of Androgenetic Alopecia in Females, 9 Beam
|
N/A | |
Terminated |
NCT03709563 -
Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss
|
N/A | |
Completed |
NCT06095739 -
Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002
|
N/A | |
Completed |
NCT03351322 -
ENERGI-F701 for Female Hair Loss Treatment
|
Phase 2 | |
Recruiting |
NCT06215469 -
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
|
N/A | |
Completed |
NCT05945979 -
Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study
|
N/A | |
Not yet recruiting |
NCT05484973 -
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
|
N/A | |
Completed |
NCT06120933 -
A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health
|
N/A | |
Withdrawn |
NCT04379583 -
HairDx Analytical Validation Study
|
||
Recruiting |
NCT05970809 -
Assessing the Safety and Efficacy of a Novel Microneedling and Laser Device for Male Pattern Hair Loss
|
N/A | |
Completed |
NCT00947219 -
Treatment of Androgenic Alopecia in Males
|
N/A | |
Not yet recruiting |
NCT03155958 -
Ocular Finding in Alopecia Areata
|
N/A | |
Enrolling by invitation |
NCT06174441 -
The Effect of 24-week Dietary Intake of Food Supplements on Hair
|
N/A | |
Unknown status |
NCT02393040 -
Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia
|
N/A | |
Completed |
NCT01016964 -
Treatment of Androgenetic Alopecia in Females, 12 Beam
|
N/A | |
Recruiting |
NCT06283316 -
Systemic Treatments for Alopecia Areata Registry
|
||
Completed |
NCT04249128 -
Nourishing Hair, Skin & Nails Supplement Study (Derm Aid)
|
Phase 3 | |
Recruiting |
NCT06117293 -
Safety and Efficacy Evaluation of the Mosaic Ultra Device
|
N/A |